VREX · TickerCove

VREXVarex Imaging CorporationHealthcare · Medical - Devicesas of 2026-09-16

Horizon

Issued 2026-09-16 at $18.47 · now $18.47 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, VREX has typically landed between $15.38 and $21.62 — a range of −16.7% to +17.1% from the issuance price $18.47.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

2,406 overlapping 1 month windows · 2017-01-20 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($18.47) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$18.47 · 99% of range

$9.32 low$18.58 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−1.2%

typical move · IQR 12.8%

−16.7%worst (p90)+17.1%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where VREX has typically landed a month from the 2026-09-16 close of $18.47 — the range is history, not a prediction.

now $18.47 (+0.0%)
typical $18.25 (-1.2%)
middle 50% $17.07–$19.43
90% range $15.38–$21.62

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,406 windows spanning 2017-01-20 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2025-03-18	−44.2%	−44.2%	+1.5%
2025-03-20	−43.9%	−44.3%	+0.0%
2025-03-19	−43.8%	−45.0%	+0.0%
3 best
2026-07-17	+75.0%	+0.0%	+76.1%
2026-07-14	+74.6%	−0.2%	+75.8%
2026-07-20	+73.8%	+0.0%	+75.0%

2,406 overlapping windows · 2017-01-20 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~10 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

56%

+3.5%

n=9

Feb

30%

−3.4%

n=10

Mar

40%

−3.7%

n=10

Apr

40%

−1.0%

n=10

May

50%

−2.1%

n=10

Jun

60%

+1.1%

n=10

Jul

70%

−0.2%

n=10

Aug

30%

+2.9%

n=10

Sep

50%

+2.0%

n=10

Oct

56%

+0.3%

n=9

Nov

67%

+7.4%

n=9

Dec

44%

+0.1%

n=9

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-09-14	Kunkel Jay K.	director	Sale	8,121 @ $18.48	$150K	−34.6% of holding	not yet — horizon still open	not yet — horizon still open	15,329	Form 4 · filed 1 day after the trade
2026-09-11	Maheshwari Shubham	officer	Sale	130,000 @ $18.46	$2.4M	−48.2% of holding	not yet — horizon still open	not yet — horizon still open	139,972	Form 4 · filed 4 days after the trade
2026-03-20	Kunkel Jay K.	director	Sale	4,510 @ $11.14	$50K	−16.1% of holding	+4.0%	not yet — horizon still open	23,450	Form 4 · filed 3 days after the trade
2025-09-19	Aranki Karen L	officer	Sale	3,174 @ $12.34	$39K	−94.7% of holding	−6.4%	−11.2%	177	Form 4 · filed 3 days after the trade
2025-08-14	Kunkel Jay K.	director	Sale	3,000 @ $10.49	$31K	−13.3% of holding	+4.0%	+19.1%	19,477	Form 4 · filed 1 day after the trade
2025-06-18	Kunkel Jay K.	director	Sale	2,575 @ $7.77	$20K	−10.3% of holding	−8.9%	+42.3%	22,477	Form 4 · filed 2 days after the trade
2025-04-02	SANYAL SUNNY	director	Sale	8,749 @ $11.24	$98K	−4.4% of holding	−24.2%	−15.5%	190,193	Form 4 · filed 1 day after the trade
2025-03-20	Honeysett Kimberley E.	officer	Sale	4,007 @ $12.81	$51K	−50.0% of holding	−35.1%	−22.9%	4,002	Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

160 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-09-11	Maheshwari Shubham	officer	Option exercise	160,944	269,972	Form 4
2026-09-11	Maheshwari Shubham	officer	Option exercise	160,944	0	Form 4
2026-08-14	Aranki Karen L	officer	Withheld for tax	1,145	7,748	Form 4
2026-08-14	Aranki Karen L	officer	Option exercise	3,974	3,975	Form 4
2026-08-14	Aranki Karen L	officer	Option exercise	3,974	8,893	Form 4
2026-08-14	Aranki Karen L	officer	Option exercise	3,974	8,893	Form 4
2026-08-14	Aranki Karen L	officer	Option exercise	3,974	8,893	Form 4
2026-08-14	Aranki Karen L	officer	Option exercise	3,974	8,893	Form 4
2026-02-12	Kunkel Jay K.	director	Award / grant	12,331	12,331	Form 4
2026-02-12	Rosebrough Walter M Jr	director	Award / grant	14,947	14,947	Form 4
2026-02-12	TSINGOS CHRISTINE A	director	Award / grant	12,331	12,331	Form 4
2026-02-12	GUERTIN TIMOTHY E	director	Award / grant	12,331	12,331	Form 4
2026-02-12	Bardwell Kathleen	director	Award / grant	12,331	12,331	Form 4
2026-02-12	Chertoff Jocelyn D	director	Award / grant	12,331	12,331	Form 4
2026-02-09	Chertoff Jocelyn D	director	Option exercise	8,483	0	Form 4
2026-02-09	TSINGOS CHRISTINE A	director	Option exercise	8,483	0	Form 4
2026-02-09	Rosebrough Walter M Jr	director	Option exercise	10,339	0	Form 4
2026-02-09	Kunkel Jay K.	director	Option exercise	8,483	0	Form 4
2026-02-09	GUERTIN TIMOTHY E	director	Option exercise	8,483	0	Form 4
2026-02-09	Bardwell Kathleen	director	Option exercise	8,483	0	Form 4
2026-02-09	Bardwell Kathleen	director	Option exercise	8,483	12,102	Form 4
2026-02-09	Kunkel Jay K.	director	Option exercise	8,483	27,960	Form 4
2026-02-09	GUERTIN TIMOTHY E	director	Option exercise	8,483	26,777	Form 4
2026-02-09	Chertoff Jocelyn D	director	Option exercise	8,483	42,194	Form 4
2026-02-09	TSINGOS CHRISTINE A	director	Option exercise	8,483	42,655	Form 4
2026-02-09	Rosebrough Walter M Jr	director	Option exercise	10,339	52,654	Form 4
2026-02-09	Bardwell Kathleen	director	Option exercise	8,483	12,102	Form 4
2026-02-09	TSINGOS CHRISTINE A	director	Option exercise	8,483	42,655	Form 4
2026-02-09	Chertoff Jocelyn D	director	Option exercise	8,483	42,194	Form 4
2026-02-09	Rosebrough Walter M Jr	director	Option exercise	10,339	52,654	Form 4
2026-02-09	GUERTIN TIMOTHY E	director	Option exercise	8,483	26,777	Form 4
2026-02-09	Kunkel Jay K.	director	Option exercise	8,483	27,960	Form 4
2025-12-15	SANYAL SUNNY	director	Award / grant	15,394	25,075	Form 4
2025-12-15	Aranki Karen L	officer	Award / grant	2,155	3,510	Form 4
2025-12-15	Aranki Karen L	officer	Award / grant	2,633	2,633	Form 4
2025-12-15	SANYAL SUNNY	director	Award / grant	18,801	18,801	Form 4
2025-12-15	Jonaitis Mark S.	officer	Award / grant	2,565	4,178	Form 4
2025-12-15	Jonaitis Mark S.	officer	Award / grant	3,134	3,134	Form 4
2025-12-15	Hartmann Andrew	officer	Award / grant	2,565	4,178	Form 4
2025-12-15	Hartmann Andrew	officer	Award / grant	3,134	3,134	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i